Skip to main content

Clavopil

An Amoxicillin-Clavulanate brand by Appealing Healthcare & Pharmacy — powder for suspension, tablet and caplet, made in India.

NAFDAC registration

Our August 2026 copy of the NAFDAC Greenbook lists 3 Clavopil registrations — one per strength or presentation. Check the number on your pack against its own line:

Listings can lag renewals — confirm the current status on the official Greenbook before buying.

Clavopil at a glance

Manufacturer
Appealing Healthcare & Pharmacy
Made by (factory)
Sparsh Bio-Tech Pvt Ltd
Comes as
Made in
India
NAFDAC reg. no.
3 registrations

Clavopil price in Nigeria

We hold no Clavopil listing of our own. Across all Amoxicillin-Clavulanate products, online pharmacy listings ranged from ₦4,040 to ₦17,280 (median ₦12,950) as of September 2026.

Figures cover Amoxicillin-Clavulanate products across brands and pack sizes, sampled from licensed Nigerian online pharmacies — indicative only. Track month-by-month movement on the Medicine Price Index.

About Amoxicillin-Clavulanate

Augmentin (amoxicillin-clavulanate) is one of the most popular and widely prescribed antibiotics in Nigeria. It combines two active ingredients: amoxicillin, a penicillin-type antibiotic, and clavulanic acid, a beta-lactamase inhibitor. Many bacteria have developed the ability to produce enzymes called beta-lactamases that can break down and inactivate amoxicillin before it can work. Clavulanic acid blocks these enzymes, allowing amoxicillin to remain effective against bacteria that would otherwise be resistant to it. This combination makes Augmentin more powerful than plain amoxicillin against a wider range of infections.

Read the full Amoxicillin-Clavulanate guide — dosage, side effects, warnings, and all registered brands.

Frequently asked questions

Registration details are shown exactly as recorded in the NAFDAC Greenbook (our copy: August 2026). Listings can lag renewals — always confirm current status on the official Greenbook before acting on it. Content updated September 2026.